

eLAMP – A novel electronic diagnostic test for bacteria and viruses has been created by researchers at the University of Surrey.
The researchers, led by Professor Johnjoe McFadden, created an electronic diagnostic test known as ‘Electro-chemical LAMP’ (eLAMP). The new test is inexpensive, quick, and sensitive.
eLAMP has the sensitivity of laboratory-based PCR testing but can be conducted at home using a smartphone.
How does the new diagnostic test work?
eLAMP converts the output of a PCR-like test called LAMP into a simple electric current. The diagnostic test device is small and has the potential to be miniaturized into a simple memory-stick-sized device that anyone with an app could operate.
The test can be performed at home because the device is tiny. The result can then be quickly relayed to health professionals to track the progress of infection and provide timely guidance to the patient.
Professor Johnjoe McFadden, corresponding author of the study and Professor of Molecular Genetics at the University of Surrey, said: “A key lesson we took from the COVID-19 pandemic is how crucial rapid, effective and cheap diagnostic tools that can be used at home are to monitoring and containing infectious diseases.
“Our test meets these criteria and can detect lower amounts of the SARS-CoV-2 virus compared to other home-based tests.
“We are looking for commercial partners to further develop the test and take it to market.”
Benefits of the test
The researchers tested human blood, saliva, and swabs from the nose and throat and discovered that their test was 93.33% accurate.
They discovered that the test works effectively at room temperature, with results available after 45 minutes.
It is critical to develop more effective coronavirus testing methods.
Since the World Health Organization declared SARS-CoV-2 a global pandemic in 2020, about six million people have died, and approximately two million cases are recorded globally every day.
The virus generally affects people’s lungs. Coughing, fever, and difficulty breathing are all symptoms. It can cause cardiac difficulties and organ failure in severe cases.
Dr Khushboo Borah Slater, co-author of the study from the University of Surrey, said: “SARS-CoV-2 is likely to be around for a long time and, unfortunately, new difficult viruses are likely to emerge.
“It’s crucial to keep working on better ways to test for the coronavirus, and our goal is to further develop our diagnostic test so that it can be easily used everywhere to help control the disease and prevent future outbreaks.”
For more details: Development of a loop-mediated isothermal amplification (LAMP)-based electrochemical test for rapid detection of SARS-CoV-2
https://doi.org/10.1016/j.isci.2023.107570
more recommended stories
Scientists Unveil Next-Gen Eye-Tracking with Unmatched Precision
Eye-tracking technology has long been a.
New Study Questions Fluid Restriction in Heart Failure Management
A groundbreaking study presented at the.
Role of Leptin Signaling in the DMH for Metabolic Regulation
A groundbreaking study from the Pennington.
COVID-19 Vaccines May Lower the Risk of Long COVID by 27%
A recent rapid review suggests that.
3D-Printed Hydrogel for Meniscus Tear Treatment
Meniscus tears are one of the.
Machine Learning Predicts Early Mortality in IBD Patients
A groundbreaking study published in the.
Endometriosis Treatment Advances: Latest Research and Therapy
Recent endometriosis treatment advances are reshaping.
Lung Cancer Screening Gaps Persist Despite Updated Guidelines
A recent study led by researchers.
Altered Knee Movement After ACL Surgery May Trigger Early Osteoarthritis
A recent study published in the.
BRP Peptide for Weight Loss: A Natural Alternative to Ozempic?
The rising obesity epidemic has fueled.
Leave a Comment